Physician
Bama Pedicatrics LLC
Bama Pedicatrics LLC was paid $3.71M by Medicaid between Jan 2018 and Dec 2024, across 76 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 25% of everything it billed.
33Billing provider infoBAMA PEDICATRICS LLC
NORTHPORT, AL 35476
NORTHPORT, AL 35476
33aNPI1720137334assigned 01/10/2007
33bProvider typeAllergy & Immunology Physician
28Total paid$3.71M
24GClaims139,726
24DCodes billed76
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Allergy & Immunology Physician providers in Alabama
Rank by total paid#1 of 15
Median peer was paid$112K
This provider vs. median33×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,182 | $337K | |
| 2019 | 13,343 | $443K | |
| 2020 | 14,245 | $410K | |
| 2021 | 25,233 | $540K | |
| 2022 | 23,444 | $530K | |
| 2023 | 26,584 | $639K | |
| 2024incomplete | 26,695 | $810K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 16,619 | 14,260 | $933K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 7,411 | 6,658 | $615K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 9.0% | 5,587 | 5,039 | $333K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.7% | 4,458 | 4,148 | $286K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.8% | 3,431 | 3,147 | $215K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.3% | 4,093 | 3,948 | $196K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 2.5% | 1,536 | 1,137 | $93K |
| 90461 | 2.4% | 1,601 | 1,573 | $89K | |
| 90670 | 2.4% | 2,192 | 2,070 | $88K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.6% | 996 | 940 | $59K |
| 90723 | 1.6% | 2,899 | 2,715 | $58K | |
| 90680 | 1.4% | 2,778 | 2,600 | $52K |
64 more codes
| 90671 | 1.3% | 1,791 | $50K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.3% | 291 | $49K |
| 90686 | 1.2% | 2,844 | $46K | |
| 99401 | 1.2% | 1,746 | $45K | |
| 90647 | 1.2% | 2,559 | $44K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.0% | 2,031 | $37K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,240 | $34K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,240 | $28K |
| 99070 | <1% | 10,893 | $26K | |
| 36416 | <1% | 11,170 | $26K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 708 | $25K |
| 92551 | <1% | 4,512 | $24K | |
| 90674 | <1% | 1,292 | $23K | |
| 95117 | <1% | 2,240 | $23K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,480 | $19K |
| 90651 | <1% | 355 | $18K | |
| 90633 | <1% | 1,051 | $17K | |
| 99381 | <1% | 248 | $15K | |
| 99173 | <1% | 3,513 | $14K | |
| 90707 | <1% | 765 | $14K | |
| 90661 | <1% | 683 | $13K | |
| 90716 | <1% | 672 | $13K | |
| 83655 | <1% | 784 | $10K | |
| 96401 | <1% | 417 | $9K | |
| 96127 | <1% | 2,638 | $9K | |
| 80061 | Lipid panel | <1% | 676 | $7K |
| 87807 | <1% | 739 | $6K | |
| 85018 | <1% | 9,255 | $6K | |
| 99177 | <1% | 364 | $6K | |
| 87631 | <1% | 126 | $5K | |
| 94010 | <1% | 181 | $3K | |
| Q3014 | Telehealth originating site facility fee | <1% | 162 | $3K |
| 90700 | <1% | 178 | $3K | |
| 0001A | <1% | 62 | $2K | |
| 90685 | <1% | 117 | $2K | |
| 90380 | <1% | 104 | $2K | |
| 83718 | <1% | 525 | $2K | |
| 0002A | <1% | 46 | $2K | |
| 0072A | <1% | 47 | $2K | |
| 96161 | <1% | 550 | $1K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 104 | $1K |
| 90381 | <1% | 82 | $1K | |
| 82465 | <1% | 256 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 23 | $915.00 |
| 0071A | <1% | 23 | $760.00 | |
| G0451 | Development testing, with interpretation and report, per standardized instrument form | <1% | 27 | $450.11 |
| 85014 | <1% | 513 | $398.98 | |
| 90672 | <1% | 16 | $340.08 | |
| 94644 | <1% | 26 | $322.00 | |
| 90696 | <1% | 29 | $277.06 | |
| 90734 | <1% | 14 | $257.27 | |
| 90620 | <1% | 13 | $197.90 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 55 | $193.16 |
| 90648 | <1% | 18 | $144.00 | |
| 90710 | <1% | 15 | $138.53 | |
| 97802 | 0% | 4,885 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 4,511 | $0.00 |
| A7015 | Aerosol mask, used with dme nebulizer | 0% | 25 | $0.00 |
| 91307 | 0% | 122 | $0.00 | |
| 1005F | 0% | 18 | $0.00 | |
| 99072 | 0% | 2,793 | $0.00 | |
| 84030 | 0% | 206 | $0.00 | |
| 96381 | 0% | 31 | $0.00 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBENNURI, BINDU (PROVIDER)